Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medical ImagingROCO:6637 +1.64%86 EBITDA Margin % is 26.37% as of Mar. 2026, which is 17% below its 10-year median of 31.72. GuruFocus rates ROCO:6637 with a GF Score™ of 86/100 and a GF Value™ of NT$129.51 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 118 Medical Distribution companies, Medical Imaging ranks better than 96.61% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Medical Imaging's EBITDA for the
three
months ended in Mar. 2026 was NT$50 Mil. Medical Imaging's Revenue for the
three
months ended in Mar. 2026 was NT$190 Mil. Therefore, Medical Imaging's EBITDA margin for the quarter that ended in Mar. 2026 was 26.37%.
Medical Imaging (ROCO:6637) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Medical Imaging EBITDA Margin % Related Terms
Medical Imaging EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Medical Imaging's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6637 vs MCK, COR, CAH: EBITDA Margin % Comparison
For the Medical Distribution subindustry, Medical Imaging's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical Imaging EBITDA Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medical Imaging's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Medical Imaging's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical Imaging (ROCO:6637) has a EBITDA Margin % of 26.37% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Medical Imaging and its competitors. This is 17% below median its historical median of 31.72. Over the past decade, Medical Imaging's EBITDA Margin % has ranged from 20.31 to 41.18. According to the industry distribution chart, Medical Imaging ranks #4 out of 118 companies in the Medical Distribution industry, placing it in the top 3.4%.
Is Medical Imaging's EBITDA Margin % too high?
Medical Imaging's current EBITDA Margin % of 26.37% is 17% below median its 10-year median of 31.72. Over the past 10 years, this metric has ranged from a low of 20.31 to a high of 41.18. The Medical Distribution industry median EBITDA Margin % is 4.16. Medical Imaging's value of 26.37% is 534.7% above this industry median. Based on the distribution chart, Medical Imaging ranks #4 out of 118 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Medical Imaging has a GF Score™ of 86/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medical Imaging's EBITDA Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Medical Imaging ranks #4 out of 118 companies for EBITDA Margin %. This places Medical Imaging in the top 3% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 4.16. Medical Imaging's value of 26.37% is 534.7% above this benchmark. Historically, Medical Imaging's own EBITDA Margin % has ranged from 20.31 to 41.18 over the past decade. While the company's 10-year median is 31.72 vs. the industry median of 4.16, Medical Imaging has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Distribution company?
The median EBITDA Margin % among Medical Distribution companies is 4.16, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medical Imaging's current EBITDA Margin % of 26.37% is 534.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Medical Imaging and its competitors. For the Medical Distribution industry, the median EBITDA Margin % is 4.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Imaging's current EBITDA Margin % is 26.37%, which is 17% below median its own 10-year median of 31.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Imaging stock overvalued right now?
Based on GuruFocus' analysis, Medical Imaging (ROCO:6637) is currently considered Possible Value Trap. The stock's GF Value™ is NT$129.51, compared to a current price of NT$62.00 — trading 52.1% below its estimated fair value. The current EBITDA Margin % is 26.37%, which is 17% below median its 10-year median of 31.72 and 534.7% above the Medical Distribution industry median of 4.16. Medical Imaging's overall GF Score™ is 86/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Medical Imaging (ROCO:6637), the current EBITDA Margin % is 26.37% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Imaging (ROCO:6637) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Imaging stock appears to be undervalued.
The current stock price of NT$62.00 is trading 52.1% below its estimated GF Value™ of NT$129.51.
GuruFocus considers Medical Imaging to be Possible Value Trap.
Key valuation signals for ROCO:6637:
EBITDA Margin %: 26.37% (17% below median its 10-year median of 31.72)
GF Value™: NT$129.51 vs. price of NT$62.00 (52.1% below fair value)
Industry Position: 534.7% above the Medical Distribution median (#4 of 118)
No single metric tells the full story. See the ROCO:6637 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Imaging Corp is a Taiwan based medical equipment company. It is engaged in medical equipment distribution, hospital equipment rental, and equipment maintenance.
86GF Score
Get the complete analysis for ROCO:6637
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6637 has been successfully added to your 
